Starting GLP-1 therapy changes how your body processes food. That is precisely the point — reduced appetite, slower gastric emptying, and improved metabolic signalling are what make these medications effective.
But here is what most patients are not told: eating significantly less means absorbing significantly fewer nutrients. And if those nutritional gaps are not addressed deliberately, they become the quiet saboteurs of your treatment — driving fatigue, muscle loss, poor sleep, GI symptoms, and eventually, weight regain.
This is not a theoretical risk. The tirzepatide prescribing information explicitly states that nutrition problems, sometimes severe, have been reported with use — including low vitamin, mineral, and protein levels. Physician guidance on nutrition and supplementation during treatment is not optional. It is part of the standard of care.
At Leanova, nutritional support is built into our programme from day one. This article explains the key areas we focus on, why each matters clinically, and how we adapt guidance for the realities of Indian diet and lifestyle.
The Core Problem: Eating Less Means Absorbing Less
GLP-1 and dual incretin therapy work partly by reducing the volume of food you consume. A patient who previously ate 2,200 kcal per day may comfortably eat 1,200–1,400 kcal during active treatment. That is a significant reduction — and with it comes a proportional reduction in micronutrient intake, unless food quality is actively managed.
Compounding this, GLP-1 therapy slows gastric emptying. This is beneficial for satiety but it also alters the gut environment in ways that can affect nutrient transit and absorption.
The result: patients on GLP-1 therapy are at meaningful risk for deficiencies in magnesium, vitamin D, B vitamins, iron, and calcium — even when they feel well and are losing weight as expected. Addressing this proactively is far easier than managing deficiency-driven symptoms after they develop.
1. Protein: The Foundation That Cannot Be Skipped
This is the single most important nutritional variable during GLP-1 treatment, and the one most commonly under-prioritised in Indian eating patterns.
When the body loses weight, it loses both fat and lean muscle mass. The ratio between the two depends heavily on protein intake and resistance exercise. Without adequate protein, a significant portion of weight lost on GLP-1 therapy comes from muscle — not fat. This matters for two reasons.
First, muscle is metabolically active. Losing it lowers your resting metabolic rate, which means your body burns fewer calories at rest. When medication is eventually tapered or stopped, this lowered metabolic rate accelerates weight regain. This is one of the primary mechanisms behind rebound weight gain after GLP-1 discontinuation.
Second, functional muscle loss affects quality of life — strength, mobility, and long-term independence, particularly relevant for patients over 40.
The target: 1.2–1.5g of protein per kg of body weight per day during active weight loss on GLP-1 therapy. For a 75kg individual, that is 90–112g of protein daily — substantially more than the average Indian diet provides without deliberate planning.
In Indian context: Traditional Indian meals are carbohydrate-dominant. Dal provides protein, but in quantities that rarely meet therapeutic targets alone. Eggs, paneer, curd, chicken, fish, and strategic legume combinations are the practical vehicles. At Leanova, our nutrition coaching specifically focuses on protein distribution across meals — because spreading adequate protein across each eating occasion maximises muscle protein synthesis more effectively than hitting a daily number in one or two meals.
The practical rule: Build the plate around a protein source first. Then add vegetables, then carbohydrates. This single habit change produces the most meaningful outcome difference in our patients.
2. Magnesium: The Most Overlooked Deficiency
Magnesium is involved in over 300 enzymatic reactions — including glucose metabolism, muscle contraction, nervous system regulation, and sleep architecture. The majority of Indian adults are already below optimal magnesium levels before starting any medication, largely because of diets high in processed foods and low in green leafy vegetables, nuts, and seeds.
GLP-1 therapy adds additional risk. Reduced food intake lowers dietary magnesium. And because GLP-1 medications improve insulin sensitivity, the resulting improvement in cellular glucose uptake can draw magnesium into cells, transiently lowering circulating levels further.
The clinical consequences are subtle and easy to misattribute. Muscle cramps. Disturbed sleep. Heightened anxiety. Fatigue that does not resolve with rest. Constipation. These are the exact complaints patients on GLP-1 therapy sometimes report — and that are frequently incorrectly blamed on the medication itself.
The form matters: Magnesium glycinate is the preferred form — it is well-absorbed, has good gastrointestinal tolerance, and the glycinate component has an independent calming effect on the nervous system. Magnesium oxide, the cheapest and most widely available form in Indian pharmacies, has poor bioavailability and predominantly acts as a laxative rather than a systemic supplement. Do not substitute one for the other.
When: Before bed. This timing aligns with sleep quality benefits and muscular recovery overnight.
3. Vitamin D3 + K2: The Pair Indian Adults Consistently Need
India has among the highest rates of vitamin D deficiency globally — a paradox for a sun-rich country, explained by indoor lifestyles, the higher melanin content of Indian skin requiring longer sun exposure for adequate synthesis, cultural dress norms limiting skin exposure, and significant urban air pollution blocking UV radiation.
In the context of obesity and insulin resistance, vitamin D deficiency is clinically meaningful. Vitamin D receptors are expressed in pancreatic beta cells, immune cells, and adipose tissue. Deficiency is associated with impaired insulin secretion, increased systemic inflammation, and poorer metabolic outcomes. During GLP-1 therapy, reduced total food intake — and in particular reduced dietary fat — can impair absorption of fat-soluble vitamins including vitamin D. Supplementation becomes especially important.
Vitamin K2 complements D3 not by enhancing its absorption, but by directing the calcium that vitamin D mobilises. Vitamin D increases calcium absorption from the gut — K2 ensures that calcium is deposited in bone where it belongs, rather than accumulating in arterial walls. For Indian patients with metabolic syndrome, where arterial calcification is already a concern, this is clinically relevant rather than incidental.
When: Morning with food — fat-soluble vitamins absorb best alongside a meal containing dietary fat. Taking these on an empty stomach substantially reduces their bioavailability.
4. Gut Health: Managing the GI Side Effects Deliberately
GLP-1 therapy slows gastric emptying by design. The clinical trade-off is that a significant proportion of patients — particularly in the first 8–12 weeks of treatment and during dose escalation — experience nausea, bloating, constipation, or altered bowel habits.
These side effects are the primary driver of premature GLP-1 discontinuation — before meaningful therapeutic weight loss has been achieved. Managing gut health proactively during this period is directly linked to treatment persistence and outcomes.
Fermented foods and probiotics help maintain the gut microbiome during a period when eating volume and food composition are both dramatically changed. In the Indian context, curd (dahi) consumed daily is one of the most practical and culturally integrated gut health tools available. For patients who can tolerate dairy, this is both evidence-adjacent and accessible. Fermented preparations like homemade idli batter, kanji, and traditional pickles (in moderation) add microbial diversity.
For patients with significant GI symptoms during titration, a multi-strain probiotic supplement taken consistently with food in the morning provides additional support. Consistency of use matters more than brand.
Dietary fibre addresses the constipation side effect directly. Psyllium husk (isabgol) — already familiar to most Indian patients, inexpensive, and widely available — is the simplest effective intervention. One teaspoon in water before a meal during symptomatic periods is a standard first-line recommendation. Adequate hydration is essential alongside any fibre supplementation.
A practical note on managing nausea during titration: smaller meal volumes, eating slowly, avoiding lying down immediately after eating, and temporarily reducing the fat content of meals (fat slows gastric emptying further, compounding the medication's effect) are the most effective non-pharmacological strategies.
5. Creatine: For Patients Who Are Exercising
This recommendation is specifically for patients engaged in resistance training alongside their GLP-1 programme — which Leanova strongly encourages from the start of treatment.
Creatine monohydrate is one of the most extensively studied sports nutrition compounds in existence. At 3–5g per day, it supports phosphocreatine availability in muscle, improving capacity for resistance work and demonstrating consistent benefit in preserving lean mass during caloric restriction. The evidence base is robust and the safety profile at these doses is well-established over decades of research.
A common concern — particularly among women — is that creatine causes excessive bulk or unwanted muscle hypertrophy. This concern is not supported by evidence at standard supplementation doses. What creatine does is help retain the muscle mass you already have during a period of significant caloric deficit. That is precisely the goal.
No loading phase is necessary. Daily consistent use at 3–5g, mixed into water or curd, is sufficient and well-tolerated by most patients.
6. B Vitamins and the Complete Micronutrient Picture
A quality complete multivitamin functions as nutritional insurance during a period of significantly reduced caloric intake — closing micronutrient gaps that even a well-managed Indian diet cannot fully cover at 1,200–1,400 kcal per day.
B vitamins deserve particular attention in the Indian context. B12 deficiency is extremely prevalent in vegetarian and vegan populations — which includes a large proportion of Indian adults. B12 deficiency progresses silently, causing fatigue, peripheral neuropathy, and cognitive changes that are often misattributed to other causes or to ageing. Testing at baseline and supplementing when indicated is standard practice in our programme.
Form matters: Methylcobalamin (B12) and methylfolate (B9) are the bioavailable forms that do not require enzymatic conversion before use. A meaningful proportion of the population carries MTHFR gene variants that reduce conversion efficiency of the cheaper cyanocobalamin (B12) and folic acid (B9) forms commonly used in standard multivitamins. Choosing methylated forms is a simple, inexpensive improvement in supplementation quality.
When: Take with the largest meal of the day for maximum absorption. B vitamins are water-soluble — excess is excreted — making toxicity risk very low at standard supplementation doses.
The Indian-Specific Gaps Most Programmes Miss
Most supplement guidance for GLP-1 therapy is written for Western populations and does not account for the specific nutritional profile of Indian adults. The gaps that matter most in our patient population are:
Iron: Indian women — particularly those with PCOS, heavy menstrual cycles, or a predominantly plant-based diet — frequently present with iron deficiency or borderline iron stores before treatment begins. Reduced food intake and altered gastric acid production during GLP-1 therapy can impair non-haem iron absorption further. Baseline iron studies and annual monitoring are standard at Leanova.
Calcium: Indian diets outside of dairy are relatively calcium-poor. For patients who are lactose intolerant, dairy-avoiding, or postmenopausal, calcium adequacy requires attention — particularly given the bone density implications of significant weight loss over time.
Zinc: Often low in predominantly cereal-based vegetarian diets. Zinc supports immune function, wound healing, and testosterone metabolism — relevant to the broader metabolic picture of patients with obesity.
Vitamin B12 specifically: Worth repeating. If you are vegetarian or vegan and have not had your B12 checked in the last year, check it now — regardless of whether you are on GLP-1 therapy.
The Bottom Line
GLP-1 therapy is extraordinarily effective when delivered correctly. The medication handles the hormonal driver of excess weight. But the outcome — in terms of body composition, durability of results, and how you feel throughout the process — depends heavily on what happens alongside the injection.
Adequate protein protects muscle. Magnesium supports sleep, nervous system function, and metabolic enzyme activity. Vitamin D and K2 address a near-universal deficiency in Indian adults. Gut support makes the treatment tolerable enough to persist with. Creatine protects lean mass for those who exercise. B vitamins close the micronutrient gaps that reduced food intake creates.
None of these are optional extras. They are the nutritional infrastructure that makes GLP-1 therapy work as it is designed to.
This is why Leanova is a programme, not a prescription.
For questions, write to us at care@leanova.in
Medical Disclaimer
This article is written for general informational and educational purposes only. The nutritional and supplementation guidance described reflects general clinical principles for patients on GLP-1 therapy and does not constitute personalised medical advice, diagnosis, or a treatment prescription.
Specific supplementation needs vary significantly between individuals based on baseline laboratory values, dietary patterns, medical history, comorbidities, and treatment phase. Not all supplements discussed are appropriate for all patients. Some supplements interact with medications or medical conditions and require clinical review before use.
All nutritional and supplement recommendations at Leanova are provided within the context of physician-supervised, individualised care following formal clinical assessment and laboratory review.
Do not start, stop, or modify supplementation based solely on information in this article without consulting a qualified healthcare provider. All treatments at Leanova are prescribed and supervised by licensed medical professionals. Individual results vary.